drugset / Trial / NCT05629468

Comparing Efficacy of Azithromycin and Probiotics for Treatment of Acne Vulgaris

NCT05629468

Phase 3 Completed 75 enrolled Pak Emirates Military Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

the goal of this clinical trial is to measure the efficacy of probiotics for treatment of acne vulgaris, to compare it with azithromycin and to measure the synergistic effect of azithromycin and probiotics for treatment of acne vulgaris

Timeline

Start
2021-10-15
Primary completion
2022-06-30
Completion
2022-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Azithromycin Small molecule 250 mg Oral
Subject Lactobacillus Unknown Oral
Background Benzoyl Peroxide 4 % Topical Cream Unknown 4 % Topical

Indications